Screening for BK viremia reduces but does not eliminate the risk of BK nephropathy: A single-center retrospective analysis

Transplantation

Volumn 95, Issue 7, 2013, Pages 949-954

  Knight, Richard J ^a   Gaber, Lillian W ^a   Patel, Samir J ^a   Devos, Jennifer M ^a   Moore, Linda W ^a   Gaber, A Osama ^a  

^a HOUSTON METHODIST HOSPITAL   (United States)

Author keywords

BK viremia; Immunosuppression; Renal transplantation

Indexed keywords

CIDOFOVIR; PREDNISONE; TACROLIMUS;

ADULT; AGE DISTRIBUTION; BK VIRUS; BK VIRUS INFECTION; CADAVER DONOR; CLINICAL EVALUATION; COHORT ANALYSIS; CONTROLLED STUDY; DESENSITIZATION; DISEASE ASSOCIATION; DISEASE CONTROL; EARLY DIAGNOSIS; ETHNIC DIFFERENCE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FUNCTION; KIDNEY GRAFT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK ASSESSMENT; RISK REDUCTION; STEROID THERAPY; TREATMENT OUTCOME; VIRAL CLEARANCE; VIREMIA; VIRUS EXAMINATION; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; BIOPSY; BK VIRUS; CYTOSINE; EARLY DIAGNOSIS; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KAPLAN-MEIER ESTIMATE; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; LOGISTIC MODELS; MALE; MASS SCREENING; MIDDLE AGED; MULTIVARIATE ANALYSIS; ORGANOPHOSPHONATES; POLYOMAVIRUS INFECTIONS; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TEXAS; TIME FACTORS; TUMOR VIRUS INFECTIONS; VIRAL LOAD; VIREMIA; YOUNG ADULT;

EID: 84876223250     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31828423cd     Document Type: Review

References (16)

1. Dadhania D, Snopkowski C, Ding R, et al. Epidemiology of BK virus in renal allograft recipients: independent risk factors for BK virus replication. Transplantation 2008; 86: 521.
2. Manitpisitkul W, Drachenberg C, Ramos E, et al. Maintenance im-munosuppressive agents as risk factors for BK virus nephropathy: a case-control study. Transplantation 2009; 88: 83.
3. Cosio F, Am H, Grande J, et al. Comparison of low versus high tacrolimus levels in kidney transplantation: assessment of efficacy by protocol biopsy. Transplantation 2007; 83: 411.
4. Dharnidharka VR, Cherikh WS, Abbott KC. An OPTN analysis of national registry data on treatment of BK virus allograft nephropathy in the United States. Transplantation 2009; 87: 1019.
5. Awadalla Y, Randhawa P, Ruppert K, et al. HLA mismatching increases the risk of BK virus nephropathy in renal transplant recipients. Am J Transplant 2004; 4: 1691.
6. Prince O, Savic S, Dickenmann M, et al. Risk factors for polyoma virus nephropathy. Nephrol Dial Transplant 2009; 24: 1024.
7. Hirsch H, Brennan DC, Drachenberg CB, et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005; 79: 1277.
8. Brennan DC, Agha I, Bohl DL, et al. Incidence of BK with tacrolimus versus cyclosporine and impact of preemptive immunosuppression reduction. Transplantation 2005; 5: 582.
9. Schaub S, Hirsch HH, Dickenmann M, et al. Reducing immunosup-pression preserves allograft function in presumptive and definitive polyomavirus- associated nephropathy. Am J Transplant 2010; 10: 2615.
10. Kidney Disease: Improving Global Outcomes (KDIGO) Transplant Work Group. KDIGO clinical practice guidelines for the care of kidney transplant recipients. Am J Transplant 2009; 9: S1.
11. Saad ER, Bresnahan BA, Cohen EP, et al. Successful treatment of BK viremia using reduction in immunosuppression without antiviral therapy. Transplantation 2008; 6: 850.
12. Alméras C, Vetromile F, Garrigue V, et al. Monthly screening for BK viremia is an effective strategy to prevent BK virus nephropathy in renal transplant recipients. Transpl Infect Dis 2011; 13: 101.
13. Vasudev B, Sundaram H, Syed AH, et al. BK virus nephritis: Risk factors, timing, and outcome in renal transplant recipients. Kidney Int 2005; 68: 1834.
14. Liacini A, Seamone ME, Muruve DA, et al. Anti-BK mechanisms of sirolimus and leflunomide alone and in combination: toward a new therapy for BK virus infection. Transplantation 2010; 90: 1450.
15. Gabardi S, Sushrut S, Martin S, et al. Evaluation of fluoroquinolones for the prevention of BKviremia after renal transplantation. Clin J Am Soc Nephrol 2010; 5: 1298.
16. Drachenberg CB, Papadimitriou JC. Polyomavirus-associated ne-phropathy: update in diagnosis. Transpl Infect Dis 2006; 8: 68.